| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |